Speaker illustration

Professor Robert Rosenson

Icahn School of Medicine at Mount Sinai, New York (United States of America)

Member of:

European Society of Cardiology

Robert S. Rosenson, MD, is Professor of Medicine at the Icahn School of Medicine at Mount Sinai, and Director of Metabolism and Lipids for the Mount Sinai Health System, New York, New York. He received his medical degree at Tulane University, New Orleans, Louisiana, and went on to complete his residency in internal medicine at Brigham and Women’s Hospital, Boston, Massachusetts, followed by a fellowship in cardiovascular medicine at The University of Chicago, Chicago, Illinois. Dr Rosenson is a Fellow of ACC, ACP, ACCP, ESC and NLA. He is the recipient of numerous awards and honors, including New York Top Doc from 2015 to 2021, USA Top Doctor in 2019, recipient of the Simon Dack Award for outstanding scholarship by JACC in 2015, 2016, 2017, 2019, 2020 and 2022.In 2017, UpToDate recognized him for 20 years of Outstanding Contributions as Editor. In 2019, he was awarded the Clinician Educator Award from the National Lipid Association.

Recurrent atherosclerotic cardiovascular disease events preventable with guideline recommended lipid-lowering treatment following myocardial infarction

Event: ESC Congress 2022

Topic: Drug therapy

Session: Lipids - Drug therapy 1

Thumbnail

Assessment of cardiovascular disease risk using different thresholds to define high risk on the pooled cohort equations

Event: ESC Congress 2018

Topic: Cardiovascular Epidemiology

Session: Atrial fibrillation, stroke and cardiovascular risk

Thumbnail

Residual risk following myocardial infarction despite intensive medical management

Event: ESC Congress 2018

Topic: Cardiovascular Pharmacotherapy, Other

Session: Antiplatelet and anticoagulant drugs

Thumbnail

Panel discussion and Q&A - Cardiovascular risk: the dangers of blood pressure and low-density lipoprotein cholesterol.

Event: ESC Congress 2017

Topic: Risk scores

Session: Cardiovascular risk: the dangers of blood pressure and low-density lipoprotein cholesterol

Thumbnail

The burden of hypertension and high cholesterol – Impact of non-compliance and failure to reach goals.

Event: ESC Congress 2017

Topic: Risk scores

Session: Cardiovascular risk: the dangers of blood pressure and low-density lipoprotein cholesterol

Thumbnail

Adherence to intensive medical management in the year following hospitalization for myocardial infarction

Event: ESC Congress 2017

Topic: Epidemiology, lipids

Session: Prevention - Epidemiology

Thumbnail

Statin use among HIV-infected adults by cardiovascular disease risk status

Event: ESC Congress 2017

Topic: Lipids (Epidemiology and Prevention)

Session: Lipid-lowering therapy: old faces and new issues

Thumbnail

Statin use and dose by low-density lipoprotein cholesterol level in U.S. commercially insured patients with type 2 diabetes

Event: ESC Congress 2016

Topic: Epidemiology, lipids

Session: Are we ever going to get to lipid goals?

Thumbnail

Increased recurrent coronary heart disease and mortality risk among intensive medically managed patients following myocardial infarction

Event: ESC Congress 2016

Topic: Epidemiology, lipids

Session: The wide world of cardiovascular research and practice

Thumbnail

Trends in high-intensity statin therapy after myocardial infarction, 2011-2014

Event: ESC Congress 2016

Topic: Epidemiology, lipids

Session: Cardiovascular risk in populations

Thumbnail